Clinical Trials List
Protocol NumberSPC-MU-201903
2019-12-01 - 2021-12-01
Phase IV
Recruiting1
ICD-10E83.00
Disorder of copper metabolism, unspecified
ICD-10E83.01
Wilson's disease
ICD-10E83.09
Other disorders of copper metabolism
ICD-9275.1
Disorders of copper metabolism
-
Trial Applicant
SHINER PHARM CORP.
-
Sponsor
-
Trial scale
Taiwan Single Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- Yin-Hsiu Chien Division of General Internal Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
23 participants
-
Global
0 participants
